eli lilly sues compounders for selling unapproved copies of tirzepatide FDA will reconsider decision barring copycat versions weight loss drug Let’s clear the air:, Yes—compounding

Weight isnt the only thing people can lose while taking a GLP-1 medication like semaglutide (Wegovy and Ozempic) or tirzepatide (Zepbound and Mounjaro)

Non-Incretin Oral Pharmacotherapies Pharmacological treatments for weight loss have expanded and, while GLP-1 agonists are the focus of this review, other choices are available and summarized here

They are often down-titrated or discontinued when patients experience hyperkalemia.[38] Observational studies, systematic reviews, and RCTs have demonstrated that discontinuing RAASis is associated with a higher risk of all-cause mortality and increased risk of kidney failure requiring dialysis.[39-41] Similar outcomes have been observed when discontinuing RAASis in patients with restored left ventricular heart failure after an acute myocardial infarction: stopping RAASis was associated with increased risk of all-cause mortality, spontaneous myocardial infarction, and heart failure rehospitalization (11.4% vs 5.4%

By using this time to develop a sustainable, nutritious semaglutide diet plan , youre setting yourself up for success long after you stop taking the medication